PARP inhibition and pharmacological ascorbate demonstrate synergy in castration-resistant prostate cancer.
bioRxiv
; 2023 Mar 23.
Article
in En
| MEDLINE
| ID: mdl-36993449
Full text:
1
Collection:
01-internacional
Health context:
6_ODS3_enfermedades_notrasmisibles
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
BioRxiv
Year:
2023
Document type:
Article